Lim Bryant David 4
4 · Prelude Therapeutics Inc · Filed May 25, 2023
Insider Transaction Report
Form 4
Lim Bryant David
CLO, CFO, Corp Sec.
Transactions
- Purchase
Common Stock
2023-05-24$5.39/sh+2,400$12,936→ 2,400 total
4 · Prelude Therapeutics Inc · Filed May 25, 2023
Common Stock